BlackRock’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $189M | Sell |
|
|||||
|
2025
Q2 | $186M | Buy |
|
|||||
|
2025
Q1 | $190M | Sell |
|
|||||
|
2024
Q4 | $145M | Sell |
|
|||||
|
2024
Q3 | $117M | Sell |
|
|||||
|
2024
Q2 | $229M | Buy |
|
|||||
|
2024
Q1 | $231M | Sell |
|
|||||
|
2023
Q4 | $274M | Buy |
|
|||||
|
2023
Q3 | $230M | Buy |
|
|||||
|
2023
Q2 | $300M | Sell |
|
|||||
|
2023
Q1 | $307M | Buy |
|
|||||
|
2022
Q4 | $280M | Buy |
|
|||||
|
2022
Q3 | $381M | Buy |
|
|||||
|
2022
Q2 | $415M | Buy |
|
|||||
|
2022
Q1 | $532M | Buy |
|
|||||
|
2021
Q4 | $410M | Buy |
|
|||||
|
2021
Q3 | $375M | Buy |
|
|||||
|
2021
Q2 | $404M | Sell |
|
|||||
|
2021
Q1 | $503M | Buy |
|
|||||
|
2020
Q4 | $425M | Buy |
|
|||||
|
2020
Q3 | $400M | Sell |
|
|||||
|
2020
Q2 | $368M | Buy |
|
|||||
|
2020
Q1 | $229M | Sell |
|
|||||
|
2019
Q4 | $317M | Buy |
|
|||||
|
2019
Q3 | $257M | Buy |
|
|||||
|
2019
Q2 | $144M | Buy |
|
|||||
|
2019
Q1 | $126M | Sell |
|
|||||
|
2018
Q4 | $143M | Buy |
|
|||||
|
2018
Q3 | $162M | Sell |
|
|||||
|
2018
Q2 | $106M | Buy |
|
|||||
|
2018
Q1 | $101M | Sell |
|
|||||
|
2017
Q4 | $150M | Sell |
|
|||||
|
2017
Q3 | $125M | Sell |
|
|||||
|
2017
Q2 | $166M | Buy |
|
|||||
|
2017
Q1 | $145M | Buy |
|
|||||
|
2016
Q4 | $355K | Sell |
|
|||||
|
2016
Q3 | $935K | Buy |
|
|||||
|
2016
Q2 | $135K | Buy |
|
|||||
|
2016
Q1 | $133K | Buy |
|
|||||
|
2015
Q4 | $86K | Buy |
|
|||||
|
2015
Q3 | $34K | Sell |
|
|||||
|
2015
Q2 | $67K | Sell |
|
|||||
|
2015
Q1 | $90K | Hold |
|
|||||
|
2014
Q4 | $90K | Sell |
|
|||||
|
2014
Q3 | $1.3M | Buy |
|
|||||
|
2014
Q2 | $94K | Buy |
|
|||||
|
2014
Q1 | $62K | Hold |
|
|||||
|
2013
Q4 | $52K | Hold |
|
|||||
|
2013
Q3 | $43K | Sell |
|
|||||
|
2013
Q2 | $34K | Buy |
|